Patents by Inventor Francisco Revert-Ros

Francisco Revert-Ros has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • GIPs, a family of polypeptides with transcription factor activity that interact with goodpasture antigen binding protein
    Patent number: 7147855
    Abstract: The present invention provides isolated GPBP-interacting 90 and 130 kDa polypeptides, and portions thereof (GIP90/130 polypeptides), antibodies to the GIP90/130 polypeptides, and pharmaceutical compositions thereof. The present invention also provides isolated GIP90/130 nucleic acid sequences, expression vectors comprising the nucleic acid sequences, and host cells transfected with the expression vectors. The invention further provides methods for detecting the GIP90/130 polypeptides or nucleic acid sequences, methods for inhibiting interactions between GPBP and GIP90/130 polypeptides, between pol k76 and GIP90/130 polypeptides or aggregation of GIP90/130 polypeptides, and methods for treating patients with autoimmune disorders or cancer.
    Type: Grant
    Filed: December 4, 2002
    Date of Patent: December 12, 2006
    Inventors: Juan Saus, Francisco Revert-Ros
  • Novel Goodpasture antigen-binding protein isoforms and protein misfolded-mediated disorders
    Publication number: 20040175758
    Abstract: The present invention provides novel isoforms of the Goodpasture antigen binding protein (GPBP), and related reagents, and also provides methods for isolating and detecting such novel GPBP isoforms. The invention further provides methods identifying compounds to treat one or more of an autoimmune condition and a protein deposit-mediated disorder, as well as novel compounds and methods for treating such conditions and/or disorders.
    Type: Application
    Filed: February 5, 2004
    Publication date: September 9, 2004
    Applicant: Dr. Juan Saus
    Inventors: Juan Saus, Fernando Revert, Francisco Revert-Ros
  • GIPs, a family of polypeptides with transcription factor activity that interact with goodpasture antigen binding protein
    Publication number: 20030108554
    Abstract: The present invention provides isolated GPBP-interacting 90 and 130 kDa polypeptides, and portions thereof (GIP90/130 polypeptides), antibodies to the GIP90/130 polypeptides, and pharmaceutical compositions thereof. The present invention also provides isolated GIP90/130 nucleic acid sequences, expression vectors comprising the nucleic acid sequences, and host cells transfected with the expression vectors. The invention further provides methods for detecting the GIP90/130 polypeptides or nucleic acid sequences, methods for inhibiting interactions between GPBP and GIP90/130 polypeptides, between pol k76 and GIP90/130 polypeptides or aggregation of GIP90/130 polypeptides, and methods for treating patients with autoimmune disorders or cancer.
    Type: Application
    Filed: December 4, 2002
    Publication date: June 12, 2003
    Inventors: Juan Saus, Francisco Revert-Ros